T. Shibutani et al., Bisphosphonate inhibits alveolar bone resorption in experimentally-inducedperi-implantitis in dogs, CLIN OR IMP, 12(2), 2001, pp. 109-114
The purpose of this study was to determine the effect of bisphosphonate on
alveolar bone resorption in experimentally-induced peri-implantitis in beag
le dogs. Experimental peri-implantitis was induced by ligation around the a
butments, 6 months after placement of a fixture. Pamidronate (0.6 mg/kg) wa
s injected intramuscularly every 3 days into each of 5 dogs. Another 5 dogs
served as the control group and were injected with saline only. Peripheral
blood and urine samples were collected every week up to 12 weeks after pla
cement of the ligature. Standard X-rays were taken every week. Urinary deox
ypyridinoline (DPD) and serum osteocalcin (OC) were evaluated by ELISA as m
arkers of alveolar bone remodeling. X-ray films were analyzed with a comput
er image analyzer. After 12 weeks, the bone level was measured after remova
l of the gingival flap. The distance between the top surface of the fixture
and the fundus of the defect was significantly lower in the Pamidronate gr
oup (1.59+/-0.55 mm, mean+/-SD) than in the control group (2.41+/-0.48 mm).
Bone density analyzed from the X-ray films was significantly higher in the
bisphosphonate group (69.2+/-8.7%, mean+/-SD) than in the control group (5
0.3+/-12.8%) after 2 to 8 weeks compared with the baseline value (100%). OC
and DPD levels fluctuated during the experimental period. These findings s
uggest that bisphosphonate inhibits the progression of alveolar bone resorp
tion during ligature-induced peri-implantitis in dogs.